Common Wart
17
2
2
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
41%
7 trials in Phase 3/4
58%
7 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (17)
Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.
Sclerotherapy and Candida Antigen in Treatment of Common Warts
Cantharidin and Occlusion in Verruca Epithelium
Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts
OM202JP Clinical Study of KNP2002
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
A Study of A-101 Topical Solution for the Treatment of Common Warts
Study of A-101 Topical Solution for the Treatment of Common Warts
Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts
Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts